P63 and Ki-67 expression in trophoblastic disease and spontaneous abortion

Journal of Research in Medical Sciences

Volumn 14, Issue 6, 2009, Pages 375-384

  Erfanian, Minoo ^a   Sharifi, Nourieh ^a   Omidi, Abas Ali ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Abortion; Choriocarcinoma; Complete hydatidiform mole; Immunohistochemistry; Ki 67; P63; Partial hydatidiform mole

Indexed keywords

KI 67 ANTIGEN; PROTEIN P63;

ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CHORIOCARCINOMA; CONTROLLED STUDY; CYTOTROPHOBLAST; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; SPONTANEOUS ABORTION; STROMA CELL; SYNCYTIOTROPHOBLAST; TROPHOBLAST; TROPHOBLASTIC DISEASE;

EID: 73349094348     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lage JM, Mark SD, Roberts DJ, Goldstein DP, Bernstein MR, Berkowitz RS. A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol 1992;79(3):403-10.
2. Paradinas FJ, Browne P, Fisher RA, Foskett M, Bagshawe KD, Newlands E. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology 1996;28(2):101-9.
3. Fukunaga M, Endo Y, Ushigome S. Flow cytometric and clinicopathologic study of 197 hydatidiform moles with special reference to the significance of cytometric aneuploidy and literature review. Cytometry 1995;22(2):135-8.
4. Coukos G, Makrigiannakis A, Chung J, Randall TC, Rubin SC, Benjamin I. Complete hydatidiform mole. A disease with a changing profile. J Reprod Med 1999;44(8):698-704.
5. Li HW, Tsao SW, Cheung AN. Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta 2002;23(1):20-31.
6. Howat AJ, Beck S, Fox H, Harris SC, Hill AS, Nicholson CM, et al. Can histopathologists reliably diagnose molar pregnancy? J Clin Pathol 1993;46(7):599-602.
7. Fukunaga M, Katabuchi H, Nagasaka T, Mikami Y, Minamiguchi S, Lage JM. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol 2005;29(7):942-7.
8. Sebire NJ, Rees H. Diagnosis of gestational trophoblastic disease in early pregnancy. Current Diagnostic Pathology 2002;8(6):430-40.
9. Petignat P, Billieux MH, Blouin JL, Dahoun S, Vassilakos P. Is genetic analysis useful in the routine management of hydatidiform mole? Hum Reprod 2003;18(2):243-9.
10. Fisher RA, Newlands ES. Gestational trophoblastic disease. Molecular and genetic studies. J Reprod Med 1998;43(1):87-97.
11. Sebire NJ, Lindsay I, Fisher RA. Recent advances in gestational trophoblastic neoplasia. Current Diagnostic Pathology 2007;13(3):210-21.
12. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;182(3):311-22.
13. Mahzouni P, Mokhtari M, Amirmansour B. Diffrentiation between reactive gliosis and astrocytomas by MIB-1/Ki67 immunostaining. J Res Med Sci 2007:12(5);241-5.
14. Maisse C, Guerrieri P, Melino G. p73 and p63 protein stability: the way to regulate function? Biochem Pharmacol 2003;66(8):1555-61.
15. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2(3):305-16.
16. Tomkova K, Tomka M, Zajac V. Contribution of p53, p63, and p73 to the developmental diseases and cancer. Neoplasma 2008;55(3):177-81.
17. Reis Filho JS, Simpson PT, Martins A, Preto A, Gartner F, Schmitt FC. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 2003;443(2):122-32.
18. Shih IM, Kurman RJ. p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol 2004;28(9):1177-83.
19. Cheville JC, Robinson R, Benda JA. Evaluation of Ki-67 (MIB-1) in placentas with hydropic change and partial and complete hydatidiform mole. Pediatr Pathol Lab Med 1996;16(1):41-50.
20. Olvera M, Harris S, Amezcua CA, McCourty A, Rezk S, Koo C, et al. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27 (kip1), and Ki-67 in normal placenta and gestational trophoblastic disease. Mod Pathol 2001;14(10):1036-42.
21. Cheung AN, Ngan HY, Collins RJ, Wong YL. Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIBI to Ki-67 antigen. J Clin Patlhol 1994;47(7):601-4.
22. Kale A, Söylemez F, Ensari A. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease. Am J Obstet Gynecol 2001;184(4):567-74.
23. Ramalho LNZ, Maggiori MS, Ribeiro-Silva A, Peres LC. P63 Expression in hydropic abortion and gestational trophoblastic diseases. Placenta 2006;27(6):740-3.
24. Kato HD, Terao Y, Ogawa M, Matsuda T, Arima T, Kato K, et al. Growth-associated gene expression profiles by microarray analysis of trophoblast of molar pregnancies and normal villi. Int J Gynecol Pathol 2002;21(3):255-60.
25. Shiozaki A, Kataoka K, Fujimura M, Yuki H, Sakai M, Saito S. Survivin inhibits apoptosis in cytotrophoblasts. Placenta 2003;24(1):65-76.